Resources

CADTH Custom Request: Impacts of COVID‑19 on First Nations, Inuit, and Métis Populations in Canada

Product: — Canadian Agency for Drugs and Technologies in Health

Ethics & Socio-cultural Socio-cultural Vulnerable Groups Vulnerable Sub-populations

covid.cadth.ca Last Updated: January 28, 2022

Also available in Français

Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Healthcare Workers Treatments

covid19-sciencetable.ca Last Updated: January 25, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 21, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 18, 2022

Fluvoxamine: What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Healthcare Workers Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 12, 2022

Baricitinib for Hospitalized Patients with COVID-19

Product: — Science Table

Drug Interventions Hospital Care Treatments

covid19-sciencetable.ca Last Updated: January 8, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 8, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: December 22, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: November 24, 2021

Design Strategies To Prevent Respiratory Infection In Congregate Care Settings

Product: — Evidence Synthesis Network

Community Prevention & Transmission Infectious Diseases & Clinical Care Practice Guidelines Public Prevention Transmission

esnetwork.ca Last Updated: November 4, 2021